Particle.news
Download on the App Store

AEW’s Rebel Reveals Primary Pulmonary Lymphoma, Begins Rehab

Treatment is paused pending infection clearance followed by a bronchoscopy to determine next steps.

Overview

  • On Nov. 16, Tanea Brooks disclosed via Instagram that Mayo Clinic diagnosed her with primary pulmonary lymphoma after a year of being treated for presumed cryptococcal pneumonia.
  • She began intensive, weekday rehab on Nov. 17 for Functional Neurological Disorder that has impaired her walking, speech, and right-hand function.
  • Doctors are treating an active infection with IV antibiotics, and cancer-directed therapy will wait until the infection resolves.
  • A third bronchoscopy is planned for December to choose a course of chemotherapy, radiation, or immunotherapy, with treatment hoped to begin around early 2026.
  • The wrestling community has posted widespread messages of support, and Brooks remains on AEW’s roster despite not appearing on television since 2022.